Christopher Pittenger MD, Ph.D.
Assistant Professor of Psychiatry, in the Child Study Center and of Psychology; Director, Yale OCD Research Clinic; Associate Director, Neuroscience Research Training Program
Departments & Organizations
2009 YCCI Scholars
Biological and Biomedical Sciences (BBS): Neuroscience
Interdepartmental Neuroscience Program
Child Study Center: NIMH Research Training Program in Childhood-onset Neuropsychiatric Disorders
Psychiatry: Connecticut Mental Health Center | Molecular Psychiatry | Obsessive Compulsive Disorder Research Clinic
Learning and memory; Habit; CREB; Adeno-associated virus; Behavioral neurobiology; Magnetic resonance spectroscopy; Glutamate; Obsessive-compulsive disorder; Tourette syndrome more...
- B.S., Yale University, 1994
- M.S., Yale University, 1994
- M.Phil., Columbia University, 1998
- Ph.D., Columbia University Graduate School of Arts and Sciences, 2002
- M.D., Columbia College of Physicians and Surgeons, 2003
- Bloch, M.H., Wasylink, S., Landeros-Weisenberger, A., Panza, K.E., Billingslea, E., Leckman, J.F., Krystal, J.H., Bhagwagar, Z., Sanacora, G., and Pittenger C. (2012). Effects of ketamine in treatment-refractory obsessive-compulsive disorder. Biological Psychiatry, in press.
- Baldan Ramsey, L.C., Xu, M., Wood, N., and Pittenger, C. (2011). Lesions of the dorsomedial striatum disrupt prepulse inhibition. Neuroscience 180:222-8.
- Pittenger, C., Bloch, M.H., and Williams, K. (2011). Glutamate abnormalities in obsessive-compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacology and Therapeutics 132:314-32.